DNA Methylation Market Share, Size, Trends, Industry Analysis Report, By Technology (PCR, Microarray, Sequencing), By Application (Gene Therapy, Diagnostics), By Product, By End-use, By Region; Segment Forecast, 2022-30

DNA Methylation Market Share, Size, Trends, Industry Analysis Report, By Technology (PCR, Microarray, Sequencing), By Application (Gene Therapy, Diagnostics), By Product, By End-use, By Region; Segment Forecast, 2022-30

The global DNA methylation market size is expected to reach USD 3,840.53 million by 2030, according to a new study by Polaris Market Research. The report “DNA Methylation Market Share, Size, Trends, Industry Analysis Report, By Technology; By Product; By Application; By End-use; By Region; Segment Forecast, 2022-2030” gives a detailed insight into current market dynamics and provides analysis on future market growth.

High consciousness and awareness about diseases, and literacy among the population are the main growth factors. Using the DNA methylation analysis method, researchers can identify possible biomarkers and understand how genes are regulated. Obesity, cancer, and other disease processes are related to abnormal DNA methylation.

The widespread commercialization of nucleic acid-based diagnostic tests & kits, along with the significant rise in the adoption of epigenetics-based treatment techniques, is anticipated to fuel market expansion. However, the expansion can be constrained by a lack of experience in DNA methylation investigations. The relatively small pool of qualified specialists continues to be a barrier to progress, despite the use of DNA methylation in a variety of biotechnological applications.

The growing use of DNA methylation in the field of agricultural genomics continues to be a highly impart force for the expansion. Additionally, it offers the possibility for use in agronomic research to examine how crops react to drought, temperature extremes, and other environmental disturbances. For instance, according to a study report in MDPI in June 2022, epigenetic marks in plants and other eukaryotes are where DNA methylation is most frequently examined. It is used as a sustainable source of diversity that supports healthy crop growth.

The widespread commercialization of nucleic acid-based diagnostic tests & kits, along with the significant rise in the adoption of epigenetics-based treatment techniques, is anticipated to fuel market expansion.

DNA Methylation Market Report Highlights

Sequencing technology segment is anticipated to grow at a CAGR over the forecast period owing to the rising use of DNA methylation in sequencing analysis

Consumables accounted for a significant percentages of global revenue share which is accelerated by the increasing usage of the consumables during the DNA methylation process to avoid contamination

Clinical research sector is expected to hold a significant market share, over the forecast period due to the rising drug discovery coupled

North America is expected to grow at a considerable CAGR over the projected period on account of the increasing adoption of DNA methylation by hospitals and pathology laboratories for diagnostics of chronic diseases

The global players include Abcam, Thermo-Fisher Scientific, and Zymo Research Corp.

Polaris Market Research has segmented the DNA methylation market report based on technology, product, application, end-use, and region:

DNA Methylation, Technology Outlook (Revenue – USD Million, 2018 – 2030)

Polymerase Chain Reaction (PCR)

Microarray

Sequencing

Other

DNA Methylation, Product Outlook (Revenue – USD Million, 2018 – 2030)

Consumables

Kits & Reagents

Enzymes

Instrument and Software

DNA Methylation, Application Outlook (Revenue – USD Million, 2018 – 2030)

Gene Therapy

Clinical Research

Diagnostics

Others

DNA Methylation, End-Use Outlook (Revenue – USD Million, 2018 – 2030)

Hospital & Diagnostic Laboratories

Pharmaceutical & Biotechnology Companies

Research & Academia

DNA Methylation, Regional Outlook (Revenue – USD Million, 2018 – 2030)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa